Enovis ENOV
NYSE ENOV
$18.68 -0.34 (-1.79%)
As of: Sep 10, 2026 · 9:56 AM EDT

Enovis (ENOV) Total Non-Current Liabilities (2010 - 2026)

Enovis' (ENOV) quarterly Total Non-Current Liabilities came in at $1.9 billion in Q3 2026, down 3.6% year-over-year from $2.0 billion in Q3 2025, and down 2.07% quarter-over-quarter from $2.0 billion in Q2 2026.

Analysis

Enovis (ENOV) Total Non-Current Liabilities (2010 - 2026) Analysis & Trends

Enovis (ENOV) has reported Total Non-Current Liabilities for 17 consecutive years, with $1.9 billion the latest figure, recorded in Q3 2026.

  • On a quarterly basis, Total Non-Current Liabilities fell 3.6% year-over-year to $1.9 billion in Q3 2026; TTM through Jul 2026 was $1.9 billion, a 3.6% decrease from a year earlier, with the FY2025 full-year figure at $1.9 billion, up 1.45% from the prior year.
  • Total Non-Current Liabilities was $1.9 billion for Q3 2026 at Enovis, down from $2.0 billion in the prior quarter.
  • Over five years, Total Non-Current Liabilities peaked at $3.2 billion in Q2 2022 and troughed at $656.5 million in Q4 2022.
  • A 5-year average of $1.6 billion and a median of $1.9 billion in 2024 frame the typical range for Total Non-Current Liabilities.
  • Across the five-year window, Total Non-Current Liabilities tumbled 82.41% in 2022 and jumped 180.61% in 2024, its largest moves.
  • Over 5 years, Total Non-Current Liabilities stood at $656.5 million in 2022, then jumped by 34.73% to $884.5 million in 2023, then jumped by 113.8% to $1.9 billion in 2024, then grew by 1.45% to $1.9 billion in 2025, then grew by 0.0% to $1.9 billion in 2026.
  • The last three Total Non-Current Liabilities figures came in at $1.9 billion (Q3 2026), $2.0 billion (Q2 2026), and $1.9 billion (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Non-Current Liabilities (Qtr)
1 Abbott Laboratories 182.70 Bn 177.10 Bn 7.27 Bn -
2 Intuitive Surgical 126.56 Bn 121.34 Bn 1.96 Bn 1.92 Bn
3 Medtronic 118.15 Bn 109.33 Bn 6.34 Bn 40.46 Bn
4 Stryker 104.94 Bn 101.46 Bn 4.50 Bn 21.28 Bn
5 Boston Scientific 64.79 Bn 64.25 Bn 3.85 Bn 17.56 Bn
6 Edwards Lifesciences 49.87 Bn 45.62 Bn 1.35 Bn 2.57 Bn
7 Alcon 33.04 Bn 31.59 Bn 1.68 Bn 6.34 Bn
8 Dexcom 32.07 Bn 30.13 Bn 830.00 Mn 3.68 Bn
9 Steris 20.78 Bn 20.29 Bn 684.20 Mn 3.44 Bn
10 Enovis 1.08 Bn 1.07 Bn 359.25 Mn 1.92 Bn
Historic Data

Historic Data

Download Data
DateValue
Jul 3, 2026 1.92 Bn
Apr 3, 2026 1.96 Bn
Dec 31, 2025 1.92 Bn
Oct 3, 2025 1.97 Bn
Jul 4, 2025 1.99 Bn
Apr 4, 2025 1.89 Bn
Dec 31, 2024 1.89 Bn
Sep 27, 2024 1.90 Bn
Jun 28, 2024 1.90 Bn
Mar 29, 2024 1.92 Bn
Dec 31, 2023 884.46 Mn
Sep 29, 2023 799.46 Mn
Jun 30, 2023 801.24 Mn
Mar 31, 2023 683.79 Mn
Dec 31, 2022 656.46 Mn
Sep 30, 2022 905.95 Mn
Jul 1, 2022 868.01 Mn
Apr 1, 2022 3.24 Bn
Dec 31, 2021 3.73 Bn
Oct 1, 2021 2.71 Bn